STOCK TITAN

Clarivate Plc - CLVT STOCK NEWS

Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.

About Clarivate Plc

Clarivate Plc (NYSE: CLVT) is a leading global provider of transformative intelligence, delivering enriched data, insights, analytics, and workflow solutions to accelerate innovation across academia, intellectual property (IP), life sciences, and government sectors. With a mission to empower organizations and researchers to bring life-changing ideas to market faster, Clarivate offers a comprehensive suite of trusted brands, including Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor®, and Techstreet™. These solutions enable customers to streamline research, manage intellectual property, and optimize pharmaceutical development.

Core Business Areas

Clarivate operates across three primary segments:

  • Academia & Government: Supporting academic institutions and government bodies with data-driven insights, library services, and discovery platforms to enhance research and learning outcomes.
  • Intellectual Property: Providing tools for patent analytics, trademark research, and IP lifecycle management, empowering organizations to protect and monetize their innovations.
  • Life Sciences & Healthcare: Delivering real-world data, analytics, and workflow solutions to pharmaceutical and biotech companies, aiding in drug discovery, regulatory compliance, and market access.

Revenue Model and Market Position

Clarivate primarily generates revenue through subscription-based services, ensuring a predictable and recurring income stream. Its portfolio also includes licensing, transactional sales, and consulting services. With operations in over 100 countries and a customer base spanning academia, government, law, healthcare, and life sciences, Clarivate is uniquely positioned as a critical enabler of innovation. The company’s focus on integrating artificial intelligence (AI) and real-world data into its offerings distinguishes it from competitors in the knowledge economy.

Strategic Initiatives

Clarivate is actively pursuing a Value Creation Plan to enhance its financial performance and operational efficiency. Key initiatives include:

  • Subscription Revenue Growth: Transitioning from low-margin transactional products to high-margin subscription-based solutions.
  • Portfolio Rationalization: Streamlining its product offerings to focus on high-growth, high-impact areas.
  • AI-Driven Innovation: Leveraging advanced technologies like AI-powered patent search and real-world data analytics to enhance customer decision-making.
  • Sales Execution: Realigning account management models and investing in customer success teams to improve client engagement and retention.

Challenges and Opportunities

While Clarivate faces challenges such as fluctuating transactional revenues and market competition, its strategic focus on innovation and recurring revenue streams positions it for long-term growth. The company’s ability to integrate AI and real-world data into its solutions offers significant opportunities to address emerging customer needs and expand its market share.

Competitive Landscape

Clarivate competes with other data and analytics providers like Elsevier, Thomson Reuters, and Springer Nature. Its differentiation lies in its comprehensive suite of products, trusted brands, and commitment to innovation. By focusing on customer-centric solutions and leveraging advanced technologies, Clarivate continues to strengthen its competitive position.

Conclusion

Clarivate Plc is more than a data provider; it is a catalyst for innovation, enabling organizations to accelerate the journey from idea to impact. With a robust portfolio of solutions, a strategic focus on subscription revenue, and a commitment to leveraging cutting-edge technologies, Clarivate remains a pivotal player in the global knowledge economy.

Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) reports Q4 and full-year 2023 financial results with a focus on revenue, net income, and cash flow. The company outlines a transformation plan for organic growth and value creation in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.45%
Tags
-
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) has been recognized in the WTR 1000 2024 by the World Trademark Review for trademark management, searching and watching, renewals, and recordals. Francois Neuville, Senior Vice President of Brand and Trademark Solutions, highlighted Clarivate's commitment to data quality and expertise, leveraging AI and tech-enabled services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) launches the Clarivate Center for IP and Innovation Research, aiming to guide corporations and research organizations in creating innovative ideas and valuable technology assets. The Center combines years of expertise in intellectual property management and data analysis to provide vital guidance for strategic IP decision-making.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
none
Rhea-AI Summary
Clarivate Plc partners with the Financial Times for the sixth year to provide high-quality data for business school rankings, including the Global MBA Rankings. The partnership aims to offer valuable insights for students and institutions, leveraging Web of Science data for research ranks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
partnership
-
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) has successfully completed the refinancing of its term loan B credit facility and extended the maturity date of its revolving credit facility. The company refinanced all existing term loans with a new $2.150 billion tranche of term loans maturing in 2031, with a reduced interest rate margin of 275 basis points per annum. The new term loan facility effectively extends the maturity of the company's existing term loans by approximately 5 years. The new term loans amortize in equal quarterly installments equivalent to 1.00% per annum, with the balance due at maturity. Concurrently, the company's revolving credit facility was refinanced with a replacement $700 million facility, extending the maturity from 2027 to 2029. Jonathan Collins, Executive Vice President and Chief Financial Officer, expressed satisfaction with the outcome, citing the oversubscribed interest in the recent offering as a testament to their solid credit profile and strong cash flow generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (NYSE:CLVT) has launched the Web of Science™ Grants Index, providing a comprehensive view of the global funding landscape with 5.2M+ awarded grant records from over 400 funders worldwide. This solution aims to empower researchers to make confident, informed decisions when seeking research funding by offering insights on funder's priorities and previously awarded grants. The integrated solution also enables researchers to identify potential new sources of funding and display details of prior funding alongside scholarly research content. Later this year, researchers will be able to claim awarded grants to their Web of Science Researcher Profiles and present published papers and citations resulting from a grant.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
none
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) will report its financial results for the fourth quarter and full year 2023 on February 27, 2024. The company will host a conference call and webcast to review the results. Interested parties can access the live audio broadcast and webcast through the investor relations section of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
conferences earnings
-
Rhea-AI Summary
Clarivate Plc (CLVT) announced the launch of a process to refinance its 2026 Term Loan B credit facility, extending the maturity to 2031 for a new combined term loan amount of $2.2 billion. The company also expects to record a non-cash goodwill impairment charge in the range of $800 million to $900 million in the fourth quarter of 2023, across its Intellectual Property and Life Sciences & Healthcare segments. This charge is expected to lower the company's 2023 forecast of a GAAP net loss, but will not impact the 2023 full-year outlook for Revenues, Organic Revenue Growth, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, and Free Cash Flow. The proposed refinancing is subject to market and other conditions, with no assurance of completion on favorable terms or at all.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (CLVT) Releases Annual Drugs to Watch Report, Predicts 13 New Therapeutics to Achieve Blockbuster Status by 2029
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6%
Tags
none
Rhea-AI Summary
Clarivate Plc (NYSE:CLVT) Launches Electrophysiology Mapping and Ablation Devices Market Insights Report Series, Predicts Pulsed-Field Ablation to Revolutionize EP Mapping and Ablation Device Market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.31%
Tags
none

FAQ

What is the current stock price of Clarivate Plc (CLVT)?

The current stock price of Clarivate Plc (CLVT) is $4.21 as of March 3, 2025.

What is the market cap of Clarivate Plc (CLVT)?

The market cap of Clarivate Plc (CLVT) is approximately 3.0B.

What does Clarivate Plc do?

Clarivate provides data, insights, and workflow solutions to accelerate innovation in academia, intellectual property, and life sciences.

How does Clarivate generate revenue?

Clarivate primarily generates revenue through subscription-based services, licensing, and consulting, ensuring a recurring income stream.

What industries does Clarivate serve?

Clarivate serves academia, government, intellectual property, life sciences, and healthcare sectors, offering tailored solutions for each industry.

What are Clarivate’s key brands?

Clarivate’s key brands include Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor®, and Techstreet™.

What is Clarivate’s Value Creation Plan?

The Value Creation Plan focuses on subscription revenue growth, portfolio rationalization, AI-driven innovation, and improved sales execution.

How does Clarivate use AI in its products?

Clarivate integrates AI into solutions like patent search and real-world data analytics to enhance decision-making and innovation workflows.

What challenges does Clarivate face?

Clarivate faces challenges such as fluctuating transactional revenues, market competition, and the need for continuous product innovation.

Who are Clarivate’s competitors?

Clarivate competes with companies like Elsevier, Thomson Reuters, and Springer Nature in the data and analytics space.

What makes Clarivate unique?

Clarivate’s comprehensive product portfolio, trusted brands, and focus on AI-driven innovation set it apart from competitors.

What are Clarivate’s future growth areas?

Clarivate aims to grow through subscription-based solutions, AI-powered innovation, and expanding its presence in high-impact sectors like life sciences.
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

3.00B
369.56M
16.38%
92.68%
6.23%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United Kingdom
ST. HELIER